Literature DB >> 24951228

Hepatocellular carcinoma in the noncirrhotic liver.

Santhosh Gaddikeri1, Michael F McNeeley, Carolyn L Wang, Puneet Bhargava, Manjiri K Dighe, Matthew M C Yeh, Theodore Jay Dubinsky, Orpheus Kolokythas, Neeraj Lalwani.   

Abstract

OBJECTIVE: Hepatocellular carcinomas (HCCs) that arise in noncirrhotic livers have several histologic and biochemical features that distinguish them from HCCs occurring in the setting of cirrhosis. Because the presentation, management, and prognosis of these entities are distinct, the accurate preoperative characterization of these lesions is of great clinical significance. We review the pathogenesis, imaging appearance, and clinical implications of noncirrhotic HCCs as they pertain to the clinical radiologist.
CONCLUSION: HCCs that develop in noncirrhotic patients have distinct etiologic, cytogenetic, histopathologic, and clinical features. Despite a larger tumor burden at the time of HCC diagnosis, noncirrhotic patients with HCC have better overall survival and disease-free survival than cirrhotic patients with HCC. Knowledge of the precise clinical and imaging features of this entity and of other diagnostic considerations for the noncirrhotic liver is essential for improved patient care.

Entities:  

Keywords:  CT; MRI; cirrhosis; hepatocellular carcinoma; noncirrhotic liver; risk factors

Mesh:

Substances:

Year:  2014        PMID: 24951228     DOI: 10.2214/AJR.13.11511

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  24 in total

1.  Two polymorphisms of USF1 gene (-202G>A and -844C>T) may be associated with hepatocellular carcinoma susceptibility based on a case-control study in Chinese Han population.

Authors:  Xu Zhou; Hua-qiang Zhu; Chao-qun Ma; Hong-guang Li; Fang-feng Liu; Hong Chang; Jun Lu
Journal:  Med Oncol       Date:  2014-11-01       Impact factor: 3.064

Review 2.  Management of people with intermediate-stage hepatocellular carcinoma: an attempted network meta-analysis.

Authors:  Davide Roccarina; Avik Majumdar; Douglas Thorburn; Brian R Davidson; Emmanuel Tsochatzis; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2017-03-10

3.  Exophytic hepatocellular carcinoma, simulating a mesenchymal tumor, in a non-cirrhotic liver.

Authors:  Glaucio Rodrigo Silva de Siqueira; Marcos Duarte Guimarães; Luiz Felipe Sias Franco; Rafaela Batista E Silva Coutinho; Edson Marchiori
Journal:  Radiol Bras       Date:  2017 Jan-Feb

Review 4.  Management of people with early- or very early-stage hepatocellular carcinoma: an attempted network meta-analysis.

Authors:  Avik Majumdar; Davide Roccarina; Douglas Thorburn; Brian R Davidson; Emmanuel Tsochatzis; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2017-03-28

5.  Diagnostic performance of Liver Imaging Reporting and Data System (LI-RADS) v2017 in predicting malignant liver lesions in pediatric patients: a preliminary study.

Authors:  Daniel R Ludwig; Erin K Romberg; Tyler J Fraum; Eric Rohe; Kathryn J Fowler; Geetika Khanna
Journal:  Pediatr Radiol       Date:  2019-05-08

6.  Clinical Importance of Incidentally Detected Hyperenhancing Liver Observations on Portal Venous Phase Computed Tomography in Patients Without Known Malignancy or Liver Disease.

Authors:  Michael T Corwin; Ryan T DiGeronimo; Shannon M Navarro; Ghaneh Fananapazir; Machelle Wilson; Thomas W Loehfelm
Journal:  J Comput Assist Tomogr       Date:  2021 Jul-Aug 01       Impact factor: 1.826

7.  Hepatocellular Carcinoma Without Cirrhosis Presenting With Hypercalcemia: Case Report and Literature Review.

Authors:  Neil B Newman; Salma K Jabbour; Jane Date C Hon; Joseph J Berman; Deen Malik; Darren Carpizo; Rebecca A Moss
Journal:  J Clin Exp Hepatol       Date:  2015-04-18

8.  Screening for hepatocellular carcinoma and cholangiocarcinoma: Can biomarkers replace imaging?

Authors:  Maria E Lozada; Roongruedee Chaiteerakij; Lewis R Roberts
Journal:  Curr Hepatol Rep       Date:  2015-06

9.  Distinguished prognosis after hepatectomy of HBV-related hepatocellular carcinoma with or without cirrhosis: a long-term follow-up analysis.

Authors:  Sheng-Li Yang; Li-Ping Liu; Yun-Fan Sun; Xing-Rong Yang; Jia Fan; Jian-Wei Ren; George G Chen; Paul B S Lai
Journal:  J Gastroenterol       Date:  2015-11-25       Impact factor: 7.527

10.  Is there an optimal staging system or liver reserve model that can predict outcome in hepatocellular carcinoma?

Authors:  Veeravich Jaruvongvanich; Tomoki Sempokuya; Linda Wong
Journal:  J Gastrointest Oncol       Date:  2018-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.